Skip to main content
XOMA Royalty Corp logo

XOMA Royalty Corp — Investor Relations & Filings

Ticker · XOMA ISIN · US98419J3059 US Financial and insurance activities
Open in API
Filings indexed 1,095 across all filing types
Latest filing 2024-12-02 M&A Activity
Country US United States of America
Listing US XOMA

About XOMA Royalty Corp

https://xoma.com/

XOMA Royalty Corp. is a biotech royalty aggregator that acquires economic rights to potential future milestone and royalty payments. The company's portfolio consists of assets associated with pre-commercial clinical candidates being developed by various pharmaceutical and biotech partners. In exchange for these economic rights, XOMA provides its partners with non-dilutive, non-recourse capital to fund their internal drug development programs. This portfolio-based strategy, encompassing over 120 assets, is designed to diversify risk away from single-asset clinical outcomes. XOMA focuses on managing these royalty assets rather than direct drug development.

Recent filings

Filing Released Lang Actions
8-K
M&A Activity Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated November 26, 2024, reporting a merger agreement and acquisition of Pulmokine, Inc. by XOMA Royalty Corporation. The text describes the merger transaction details, including payment terms and structure, and references an attached press release. There are no financial statements or detailed financial analysis included, only a description of the merger event. This type of filing is typically categorized under M&A Activity (TAR) as it announces a merger transaction. The document length is under 5,000 characters and it is a current report on a material event, not a full merger proxy or tender offer filing (which would be MA). Therefore, the best classification is M&A Activity (TAR).
2024-12-02 English
PRIMARY DOCUMENT
Director's Dealing
2024-11-13 English
PRIMARY DOCUMENT
Director's Dealing
2024-11-13 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K current report filed with the SEC, dated November 7, 2024. It announces the issuance of a press release reporting the company's financial results for the quarter ended September 30, 2024. The text explicitly states that the full press release is attached as an exhibit and incorporated by reference, but the 8-K itself does not contain detailed financial statements or substantive financial data. The document is short (3861 characters) and serves as an announcement of the earnings release rather than the earnings release itself. According to the rules, such announcements are classified as Earnings Release (ER) if they contain key highlights only, but since this is a Form 8-K referencing a press release with financial results, it fits best as an Earnings Release (ER).
2024-11-07 English
10-Q
Interim / Quarterly Report Q3 2024
2024-11-07 English
8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes a transaction where XOMA Royalty Corporation entered into a Royalty Purchase Agreement involving a $15 million cash payment for certain royalty rights. It also mentions an attached press release about the transaction. There are no detailed financial statements or comprehensive financial analysis included, just a description of the transaction and reference to a press release. This fits the category of a Capital/Financing Update (CAP), as it relates to a financing activity involving payment and acquisition of royalty interests. The document length is under 5,000 characters, but it contains substantive information about the transaction itself, not just an announcement of a report. Therefore, the best classification is CAP with high confidence.
2024-10-22 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.